A vaccine for all mankind: Sputnik V’s efficacy in fighting COVID-19 is validated by internationally peer reviewed data published in The Lancet

  • In an interim analysis of a Phase III clinical trial, Sputnik V showed strong efficacy, immunogenicity and safety results.
  • Efficacy of Sputnik V against COVID-19 was reported at 91.6%.
    Sputnik V provides full protection against severe cases of COVID-19.
    Among the cases analyzed, over 98% of volunteers developed humoral immune response and 100% – cellular immune response.
    The level of virus neutralizing antibodies of volunteers vaccinated with Sputnik V is 1.3-1.5 times higher than the level of antibodies of patients who recovered from COVID-19.
    Excellent safety profile. Most adverse events (94%) were mild and included flu-like syndromes, injection site reactions, headache and asthenia.
    Sputnik V is one of the three vaccines in the world with efficacy of over 90%. Furthermore, Sputnik V stands out among these vaccines thanks to a number of key advantages:
    Sputnik V is already registered in 16 countries: Russia, Belarus, Serbia, Argentina, Bolivia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, UAE, Iran, Republic of Guinea, Tunisia and Armenia.
    In the first week of February, vaccination with Sputnik V will start in the following 12 countries: Bolivia, Kazakhstan, Turkmenistan, Palestine, UAE, Paraguay, Hungary, Armenia, Algeria, Bosnian Serb Republic, Venezuela and Iran.

    Moscow, February 2, 2021 – The Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announce that the Lancet, one of the world’s oldest and most respected medical journals, has published interim results of a Phase III clinical trial of Sputnik V, confirming the vaccine’s high efficacy and safety. Sputnik V, which is based on a well-studied human adenoviral vectors platform, is the world’s first registered vaccine against coronavirus.

    In the interim efficacy analysis of the randomized, double-blind, placebo-controlled clinical trial, where data on 19,866 volunteers were included in the efficacy analysis (14,964 of whom received the vaccine and 4,902 the placebo), the two-dose treatment of Sputnik V administered 21 days apart demonstrated efficacy of 91.6% against COVID-19. The calculation is based on the analysis of 78 confirmed cases of COVID-19 identified in the placebo group (62 cases) and in the vaccine group (16 cases). Sputnik V generated a robust humoral and cell mediated immune response.

image_pdfimage_print

Democracy Index ranks Taiwan top in Asia, 11th globally

The Legislative Yuan’s last day of reviewing the government’s 2021 budget on Jan. 29.

Taipei, Feb. 3 (CNA) Taiwan has jumped 20 places in the 2020 Democracy Index rankings to 11th position globally from 31st in 2019, to rank top in Asia, according to the index report released Tuesday by the Economist Intelligence Unit (EIU).

Describing Taiwan as a beacon of democracy in Asia, the report said that the country’s spectacular rise reflects a consolidation of positive political and legal development in recent years.

“The transparency of the financing of political parties has improved and legislative reforms have more explicitly affirmed the judiciary’s independence from government influence,” according to the report.

The EIU began compiling the Democracy Index in 2006 and the main focus of the 2020 report is the impact of the coronavirus (COVID-19) pandemic on democracy and freedom around the world.

The global average score in the 2020 Democracy Index hit an all-time low, falling from 5.44 in 2019 to 5.37. This is by far the worst global score since the index was first produced in 2006, according to the report.

In 2020, a large majority of countries — 116 of a total of 167 polled — recorded a decline in their total scores compared with the previous year. Only 38 recorded an improvement, the report said, noting that the star performer in this year’s index is Taiwan, which was upgraded from a “flawed democracy” to a “full democracy.”

Based on its scores on a range of indicators, each country is then itself classified as one of four types of regime: “full democracy;” “flawed democracy;” “hybrid regime,” or “authoritarian regime.”.

According to the EIU’s measure of democracy, only about 49.4 percent of the world’s population live in a democracy of some sort, and just 8.4 percent reside in a “full democracy.”

More than one-third — 35.6 percent of the world’s population — live under authoritarian rule, with a large share being in China, the report revealed.

The top five places in the global democracy rankings were occupied by Norway, Iceland, Sweden, New Zealand and Canada.

Taiwan, Japan and South Korea took the top three spots in Asia, moving from the “flawed democracy” category to be classified as “full democracies.”

(By Chen Yi-wei and Evelyn Kao)

Enditem/J

image_pdfimage_print